File Download

There are no files associated with this item.

Supplementary

Conference Paper: Reduction of Placental Thioredoxin Expression in Diabetic Pregnancies

TitleReduction of Placental Thioredoxin Expression in Diabetic Pregnancies
Authors
Issue Date2006
PublisherAmerican Society for Cell Biology
Citation
American Society for Cell Biology 46th Annual Meeting, San Diego, CA, 9-13 December 2006. In Late Abstracts: The American Society for Cell Biology 46th Annual Meeting, Abstract no. L147 How to Cite?
AbstractGestational diabetes mellitus (GDM) is defined as glucose intolerance with its first onset recognized during pregnancy. Patients from GDM are subjected to increase oxidative stress and reduced activity of the placental antioxidant enzymes, all of which contribute to the increase in tissues damages and is associated with adverse perinatal outcome. Thioredoxin (Trx) is a small multifunctional protein ubiquitously expressed in many different tissues. In normal human placenta, it is localized in the trophoblastic region and plays a protective role against oxidative stress in the placenta. Here, a prospective study was carried out in which high-risk women with singleton pregnancies were recruited from the clinic for placental studies. Following delivery, placental specimens were collected and placental protein expression of Trx and TrxR was measured by western blot analysis. A significant reduction of placental Trx and TrxR protein expression was found in diabetic pregnancies in comparison to normal pregnancies. In addition, the reduction of the expression on the two proteins was negatively correlated with the severity of glucose intolerance. In line with the placental Trx protein expression level, we also demonstrated a decrease in placental Trx mRNA expression level in GDM patients, suggesting a possible transcription level down-regulatory mechanism of Trx in GDM patients. Furthermore, using immunohistochemitry techniques, we showed that this reduction of Trx expression was mainly localized in the stromal region of the placental villi. Taking together, we have demonstrated a reduction in placental Trx expression in GDM patients, and further investigation is required to elucidate the role of Trx in GDM placenta.
Persistent Identifierhttp://hdl.handle.net/10722/96298

 

DC FieldValueLanguage
dc.contributor.authorLee, TCWen_HK
dc.contributor.authorWong, NSen_HK
dc.contributor.authorLao, TTen_HK
dc.date.accessioned2010-09-25T16:29:30Z-
dc.date.available2010-09-25T16:29:30Z-
dc.date.issued2006en_HK
dc.identifier.citationAmerican Society for Cell Biology 46th Annual Meeting, San Diego, CA, 9-13 December 2006. In Late Abstracts: The American Society for Cell Biology 46th Annual Meeting, Abstract no. L147-
dc.identifier.urihttp://hdl.handle.net/10722/96298-
dc.description.abstractGestational diabetes mellitus (GDM) is defined as glucose intolerance with its first onset recognized during pregnancy. Patients from GDM are subjected to increase oxidative stress and reduced activity of the placental antioxidant enzymes, all of which contribute to the increase in tissues damages and is associated with adverse perinatal outcome. Thioredoxin (Trx) is a small multifunctional protein ubiquitously expressed in many different tissues. In normal human placenta, it is localized in the trophoblastic region and plays a protective role against oxidative stress in the placenta. Here, a prospective study was carried out in which high-risk women with singleton pregnancies were recruited from the clinic for placental studies. Following delivery, placental specimens were collected and placental protein expression of Trx and TrxR was measured by western blot analysis. A significant reduction of placental Trx and TrxR protein expression was found in diabetic pregnancies in comparison to normal pregnancies. In addition, the reduction of the expression on the two proteins was negatively correlated with the severity of glucose intolerance. In line with the placental Trx protein expression level, we also demonstrated a decrease in placental Trx mRNA expression level in GDM patients, suggesting a possible transcription level down-regulatory mechanism of Trx in GDM patients. Furthermore, using immunohistochemitry techniques, we showed that this reduction of Trx expression was mainly localized in the stromal region of the placental villi. Taking together, we have demonstrated a reduction in placental Trx expression in GDM patients, and further investigation is required to elucidate the role of Trx in GDM placenta.-
dc.languageengen_HK
dc.publisherAmerican Society for Cell Biology-
dc.relation.ispartofLate Abstracts: The American Society for Cell Biology 46th Annual Meetingen_HK
dc.titleReduction of Placental Thioredoxin Expression in Diabetic Pregnanciesen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailWong, NS: nswong@hkucc.hku.hken_HK
dc.identifier.authorityWong, NS=rp00340en_HK
dc.identifier.hkuros132438en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats